These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 942272

  • 1. Circulating immunoblasts in polymyalgia rheumatica.
    Eghtedari AA, Esselinckx W, Bacon PA.
    Ann Rheum Dis; 1976 Apr; 35(2):158-62. PubMed ID: 942272
    [Abstract] [Full Text] [Related]

  • 2. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [Abstract] [Full Text] [Related]

  • 3. Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins.
    Eghtedari AA, Davis P, Bacon PA.
    Ann Rheum Dis; 1976 Apr; 35(2):155-7. PubMed ID: 942271
    [Abstract] [Full Text] [Related]

  • 4. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS, Abdulahad WH, Chalan P, Rutgers A, Horst G, Huitema MG, Roffel MP, Roozendaal C, Kluin PM, Bos NA, Boots AM, Brouwer E.
    Arthritis Rheumatol; 2014 Jul; 66(7):1927-38. PubMed ID: 24623536
    [Abstract] [Full Text] [Related]

  • 5. Presenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective study.
    Caporali R, Montecucco C, Epis O, Bobbio-Pallavicini F, Maio T, Cimmino MA.
    Ann Rheum Dis; 2001 Nov; 60(11):1021-4. PubMed ID: 11602472
    [Abstract] [Full Text] [Related]

  • 6. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
    McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, Molloy ES, Kenny D, McCarthy GM.
    J Rheumatol; 2014 May; 41(5):931-7. PubMed ID: 24692520
    [Abstract] [Full Text] [Related]

  • 7. Polymyalgia rheumatica. Assessment of disease activity using erythrocyte sedimentation rate and plasma viscosity.
    Esselinckx W, Bucknall RC, Dixon AS.
    Ann Rheum Dis; 1977 Dec; 36(6):560-2. PubMed ID: 596948
    [Abstract] [Full Text] [Related]

  • 8. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
    Kyle V, Cawston TE, Hazleman BL.
    Ann Rheum Dis; 1989 Aug; 48(8):667-71. PubMed ID: 2782977
    [Abstract] [Full Text] [Related]

  • 9. Increased RAHA titer and interleukin-6 levels in the synovial fluid in a patient with polymyalgia rheumatica.
    Zen-nyoji A, Shimizu H, Ohtani K, Oshimoto K, Kobayashi Y, Mori M.
    Intern Med; 1993 Jun; 32(6):484-6. PubMed ID: 8241593
    [Abstract] [Full Text] [Related]

  • 10. HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity.
    Salvarani C, Boiardi L, Mantovani V, Ranzi A, Cantini F, Olivieri I, Bragliani M, Collina E, Macchioni P.
    Ann Rheum Dis; 1999 May; 58(5):303-8. PubMed ID: 10225816
    [Abstract] [Full Text] [Related]

  • 11. CD8 lymphocyte subsets in active polymyalgia rheumatica: comparison with elderly-onset and adult rheumatoid arthritis and influence of prednisone therapy.
    Boiardi L, Salvarani C, Macchioni P, Casadei Maldini M, Mancini R, Beltrandi E, Portioli I.
    Br J Rheumatol; 1996 Jul; 35(7):642-8. PubMed ID: 8670597
    [Abstract] [Full Text] [Related]

  • 12. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study.
    Cantini F, Salvarani C, Olivieri I, Macchioni L, Ranzi A, Niccoli L, Padula A, Boiardi L.
    Semin Arthritis Rheum; 2000 Aug; 30(1):17-24. PubMed ID: 10966209
    [Abstract] [Full Text] [Related]

  • 13. Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate.
    Cantini F, Salvarani C, Olivieri I, Niccoli L, Macchioni P, Boiardi L, Mastrorosato M, Ciancio G, Padula A, Bozza A, Rubini F.
    Arthritis Rheum; 2001 May; 44(5):1155-9. PubMed ID: 11352249
    [Abstract] [Full Text] [Related]

  • 14. The relation of polymyalgia rheumatica to rheumatoid arthritis.
    Healey LA, Sheets PK.
    J Rheumatol; 1988 May; 15(5):750-2. PubMed ID: 3262751
    [Abstract] [Full Text] [Related]

  • 15. [The support of the ultrasonography of the shoulder in the diagnosis of polymyalgia rheumatica with normal erythrocyte sedimentation rate].
    Zaccaria A, Latinakis G, Oliveri M, Maio T, Frisone G, Versace F.
    Reumatismo; 2009 May; 61(4):290-7. PubMed ID: 20143005
    [Abstract] [Full Text] [Related]

  • 16. Peripheral musculoskeletal manifestations in polymyalgia rheumatica.
    Ceccato F, Roverano SG, Papasidero S, Barrionuevo A, Rillo OL, Paira SO.
    J Clin Rheumatol; 2006 Aug; 12(4):167-71. PubMed ID: 16891918
    [Abstract] [Full Text] [Related]

  • 17. Is the course of steroid-treated polymyalgia rheumatica more severe in women?
    Cimmino MA, Parodi M, Caporali R, Montecucco C.
    Ann N Y Acad Sci; 2006 Jun; 1069():315-21. PubMed ID: 16855159
    [Abstract] [Full Text] [Related]

  • 18. Polymyalgia rheumatica with normal erythrocyte sedimentation rate: clinical aspects.
    Martínez-Taboada VM, Blanco R, Rodríguez-Valverde V.
    Clin Exp Rheumatol; 2000 Jun; 18(4 Suppl 20):S34-7. PubMed ID: 10948758
    [Abstract] [Full Text] [Related]

  • 19. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.
    Proven A, Gabriel SE, O'Fallon WM, Hunder GG.
    J Rheumatol; 1999 Jun; 26(6):1333-7. PubMed ID: 10381052
    [Abstract] [Full Text] [Related]

  • 20. Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica.
    Shimojima Y, Matsuda M, Gono T, Ishii W, Ikeda S.
    Intern Med; 2005 Sep; 44(9):1009-12. PubMed ID: 16258224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.